Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Reduced skeletal muscle expression of mitochondrial-derived peptides humanin and MOTS-C and Nrf2 in chronic kidney disease.

Liu C, Gidlund EK, Witasp A, Qureshi AR, Söderberg M, Thorell A, Nader GA, Barany P, Stenvinkel P, von Walden F.

Am J Physiol Renal Physiol. 2019 Nov 1;317(5):F1122-F1131. doi: 10.1152/ajprenal.00202.2019. Epub 2019 Aug 21.

PMID:
31432706
2.

Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease.

Dai L, Watanabe M, Qureshi AR, Mukai H, Machowska A, Heimbürger O, Barany P, Lindholm B, Stenvinkel P.

Eur J Intern Med. 2019 Oct;68:60-65. doi: 10.1016/j.ejim.2019.07.035. Epub 2019 Aug 9.

PMID:
31402276
3.

Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study.

Laureati P, Xu Y, Trevisan M, Schalin L, Mariani I, Bellocco R, Sood MM, Barany P, Sjölander A, Evans M, Carrero JJ.

Nephrol Dial Transplant. 2019 Aug 4. pii: gfz150. doi: 10.1093/ndt/gfz150. [Epub ahead of print]

PMID:
31377791
4.

Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine measurements project.

Runesson B, Trevisan M, Iseri K, Qureshi AR, Lindholm B, Barany P, Elinder CG, Carrero JJ.

Nephrol Dial Transplant. 2019 Jul 30. pii: gfz142. doi: 10.1093/ndt/gfz142. [Epub ahead of print]

PMID:
31361316
5.

Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study.

Pei M, Aguiar R, Pagels AA, Heimbürger O, Stenvinkel P, Bárány P, Medin C, Jacobson SH, Hylander B, Lindholm B, Qureshi AR.

BMC Nephrol. 2019 Apr 29;20(1):144. doi: 10.1186/s12882-019-1318-x.

6.

Erratum to 'Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists' [Eur J Heart Fail 2018;20:1217-1226].

Trevisan M, de Deco P, Xu H, Evans M, Lindholm B, Bellocco R, Barany P, Jernberg T, Lund LH, Carrero JJ.

Eur J Heart Fail. 2019 Apr;21(4):540. doi: 10.1002/ejhf.1367. Epub 2018 Nov 26. No abstract available.

PMID:
30969476
7.

Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial Infarction.

Mok Y, Ballew SH, Sang Y, Grams ME, Coresh J, Evans M, Barany P, Ärnlöv J, Carrero JJ, Matsushita K.

J Am Heart Assoc. 2019 Apr 16;8(8):e010546. doi: 10.1161/JAHA.118.010546.

8.

Estimated Glomerular Filtration Rate and the Risk of Cancer.

Xu H, Matsushita K, Su G, Trevisan M, Ärnlöv J, Barany P, Lindholm B, Elinder CG, Lambe M, Carrero JJ.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):530-539. doi: 10.2215/CJN.10820918. Epub 2019 Mar 14.

PMID:
30872279
9.

Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients.

Chen Z, Qureshi AR, Brismar TB, Ripsweden J, Haarhaus M, Barany P, Heimburger O, Lindholm B, Stenvinkel P.

BMC Nephrol. 2019 Feb 18;20(1):59. doi: 10.1186/s12882-019-1235-z.

10.

Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project.

Runesson B, Qureshi AR, Xu H, Gasparini A, Lindholm B, Barany P, Elinder CG, Carrero JJ.

PLoS One. 2019 Jan 16;14(1):e0209440. doi: 10.1371/journal.pone.0209440. eCollection 2019.

11.

Inverse J-shaped relation between coronary arterial calcium density and mortality in advanced chronic kidney disease.

Mukai H, Dai L, Chen Z, Lindholm B, Ripsweden J, Brismar TB, Heimbürger O, Barany P, Qureshi AR, Söderberg M, Bäck M, Stenvinkel P.

Nephrol Dial Transplant. 2018 Dec 7. doi: 10.1093/ndt/gfy352. [Epub ahead of print]

PMID:
30534995
12.

Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease.

Feldreich T, Nowak C, Fall T, Carlsson AC, Carrero JJ, Ripsweden J, Qureshi AR, Heimbürger O, Barany P, Stenvinkel P, Vuilleumier N, Kalra PA, Green D, Ärnlöv J.

J Nephrol. 2019 Feb;32(1):111-119. doi: 10.1007/s40620-018-0556-5. Epub 2018 Nov 29.

13.

Fibroblast growth factor 23 is associated with fractional excretion of sodium in patients with chronic kidney disease.

Xu H, Hashem A, Witasp A, Mencke R, Goldsmith D, Barany P, Bruchfeld A, Wernerson A, Carrero JJ, Olauson H.

Nephrol Dial Transplant. 2018 Oct 11. doi: 10.1093/ndt/gfy315. [Epub ahead of print]

PMID:
30312430
14.

Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study.

Levin A, Nair D, Qureshi AR, Bárány P, Heimburger O, Anderstam B, Stenvinkel P, Bruchfeld A, Ungerstedt JS.

Nephron. 2018;140(4):249-256. doi: 10.1159/000492500. Epub 2018 Sep 25.

PMID:
30253414
15.

Ferrocene-Containing Impiridone (ONC201) Hybrids: Synthesis, DFT Modelling, In Vitro Evaluation, and Structure⁻Activity Relationships.

Bárány P, Oláh RS, Kovács I, Czuczi T, Szabó CL, Takács A, Lajkó E, Láng O, Kőhidai L, Schlosser G, Bősze S, Mező G, Hudecz F, Csámpai A.

Molecules. 2018 Sep 3;23(9). pii: E2248. doi: 10.3390/molecules23092248.

16.

Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine Measurements (SCREAM) project.

Gasparini A, Evans M, Barany P, Xu H, Jernberg T, Ärnlöv J, Lund LH, Carrero JJ.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1534-1541. doi: 10.1093/ndt/gfy249.

17.

Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease: The Stockholm CREAtinine Measurements (SCREAM) Project.

Carrero JJ, Trevisan M, Sood MM, Bárány P, Xu H, Evans M, Friberg L, Szummer K.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1314-1320. doi: 10.2215/CJN.04060318. Epub 2018 Jul 20.

18.

Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease.

Mukai H, Ming P, Lindholm B, Heimbürger O, Barany P, Anderstam B, Stenvinkel P, Qureshi AR.

PLoS One. 2018 Apr 27;13(4):e0195585. doi: 10.1371/journal.pone.0195585. eCollection 2018.

19.

Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists.

Trevisan M, de Deco P, Xu H, Evans M, Lindholm B, Bellocco R, Barany P, Jernberg T, Lund LH, Carrero JJ.

Eur J Heart Fail. 2018 Aug;20(8):1217-1226. doi: 10.1002/ejhf.1199. Epub 2018 Apr 18. Erratum in: Eur J Heart Fail. 2019 Apr;21(4):540.

20.

Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease.

Mukai H, Ming P, Lindholm B, Heimbürger O, Barany P, Stenvinkel P, Qureshi AR.

Kidney Blood Press Res. 2018;43(2):522-535. doi: 10.1159/000488699. Epub 2018 Mar 29.

21.

Lower serum calcium is independently associated with CKD progression.

Janmaat CJ, van Diepen M, Gasparini A, Evans M, Qureshi AR, Ärnlöv J, Barany P, Elinder CG, Rotmans JI, Vervloet M, Dekker FW, Carrero JJ.

Sci Rep. 2018 Mar 26;8(1):5148. doi: 10.1038/s41598-018-23500-5.

22.

Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidism.

Evans M, Methven S, Gasparini A, Barany P, Birnie K, MacNeill S, May MT, Caskey FJ, Carrero JJ.

Sci Rep. 2018 Feb 1;8(1):2103. doi: 10.1038/s41598-018-20552-5.

23.

Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.

Mukai H, Svedberg O, Lindholm B, Dai L, Heimbürger O, Barany P, Anderstam B, Stenvinkel P, Qureshi AR.

Nephrol Dial Transplant. 2019 Mar 1;34(3):442-448. doi: 10.1093/ndt/gfx371.

PMID:
29378035
24.

The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease.

Alves FC, Sun J, Qureshi AR, Dai L, Snaedal S, Bárány P, Heimbürger O, Lindholm B, Stenvinkel P.

PLoS One. 2018 Jan 3;13(1):e0190410. doi: 10.1371/journal.pone.0190410. eCollection 2018.

25.

Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients.

Dai L, Mukai H, Lindholm B, Heimbürger O, Barany P, Stenvinkel P, Qureshi AR.

PLoS One. 2017 Dec 6;12(12):e0186659. doi: 10.1371/journal.pone.0186659. eCollection 2017.

26.

Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time.

van Craenenbroeck AH, Bragfors-Helin AC, Qureshi AR, Lindholm B, Sjöberg B, Anderstam B, Heimburger O, Stenvinkel P, Bárány P.

Kidney Blood Press Res. 2017;42(5):877-885. doi: 10.1159/000484537. Epub 2017 Nov 22.

27.

eGFR and the Risk of Community-Acquired Infections.

Xu H, Gasparini A, Ishigami J, Mzayen K, Su G, Barany P, Ärnlöv J, Lindholm B, Elinder CG, Matsushita K, Carrero JJ.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1399-1408. doi: 10.2215/CJN.00250117. Epub 2017 Aug 17.

28.

The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.

Tranæus Lindblad Y, Olauson H, Vavilis G, Hammar U, Herthelius M, Axelsson J, Bárány P.

Pediatr Nephrol. 2018 Jan;33(1):147-157. doi: 10.1007/s00467-017-3766-5. Epub 2017 Aug 9.

29.

Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.

Szummer K, Gasparini A, Eliasson S, Ärnlöv J, Qureshi AR, Bárány P, Evans M, Friberg L, Carrero JJ.

J Am Heart Assoc. 2017 Mar 1;6(3). pii: e004925. doi: 10.1161/JAHA.116.004925.

30.

CDKN2A/p16INK4a expression is associated with vascular progeria in chronic kidney disease.

Stenvinkel P, Luttropp K, McGuinness D, Witasp A, Qureshi AR, Wernerson A, Nordfors L, Schalling M, Ripsweden J, Wennberg L, Söderberg M, Bárány P, Olauson H, Shiels PG.

Aging (Albany NY). 2017 Feb 9;9(2):494-507. doi: 10.18632/aging.101173.

31.

Does statins promote vascular calcification in chronic kidney disease?

Chen Z, Qureshi AR, Parini P, Hurt-Camejo E, Ripsweden J, Brismar TB, Barany P, Jaminon AM, Schurgers LJ, Heimbürger O, Lindholm B, Stenvinkel P.

Eur J Clin Invest. 2017 Feb;47(2):137-148. doi: 10.1111/eci.12718.

PMID:
28036114
32.

Increased Telomere Attrition After Renal Transplantation-Impact of Antimetabolite Therapy.

Luttropp K, Nordfors L, McGuinness D, Wennberg L, Curley H, Quasim T, Genberg H, Sandberg J, Sönnerborg I, Schalling M, Qureshi AR, Bárány P, Shiels PG, Stenvinkel P.

Transplant Direct. 2016 Nov 16;2(12):e116. eCollection 2016 Dec.

33.

Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.

Carrero JJ, Grams ME, Sang Y, Ärnlöv J, Gasparini A, Matsushita K, Qureshi AR, Evans M, Barany P, Lindholm B, Ballew SH, Levey AS, Gansevoort RT, Elinder CG, Coresh J.

Kidney Int. 2017 Jan;91(1):244-251. doi: 10.1016/j.kint.2016.09.037. Epub 2016 Dec 4.

34.

Bone mineral density of extremities is associated with coronary calcification and biopsy-verified vascular calcification in living-donor renal transplant recipients.

Chen Z, Sun J, Haarhaus M, Barany P, Wennberg L, Ripsweden J, Brismar TB, Lindholm B, Wernerson A, Söderberg M, Stenvinkel P, Qureshi AR.

J Bone Miner Metab. 2017 Sep;35(5):536-543. doi: 10.1007/s00774-016-0788-1. Epub 2016 Dec 2.

PMID:
27913900
35.

Prevalence and recognition of chronic kidney disease in Stockholm healthcare.

Gasparini A, Evans M, Coresh J, Grams ME, Norin O, Qureshi AR, Runesson B, Barany P, Ärnlöv J, Jernberg T, Wettermark B, Elinder CG, Carrero JJ.

Nephrol Dial Transplant. 2016 Dec;31(12):2086-2094. Epub 2016 Oct 13.

36.

Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.

Machowska A, Sun J, Qureshi AR, Isoyama N, Leurs P, Anderstam B, Heimburger O, Barany P, Stenvinkel P, Lindholm B.

PLoS One. 2016 Oct 4;11(10):e0163826. doi: 10.1371/journal.pone.0163826. eCollection 2016.

37.

Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anaemic chronic kidney disease patients.

Evans M, Carrero JJ, Bellocco R, Barany P, Qureshi AR, Seeberger A, Jacobson SH, Hylander-Rössner B, Rotnitzky A, Sjölander A.

Nephrol Dial Transplant. 2017 Nov 1;32(11):1892-1901. doi: 10.1093/ndt/gfw328.

PMID:
27672090
38.

Do metabolic derangements in end-stage polycystic kidney disease differ versus other primary kidney diseases?

Jankowska M, Qureshi AR, Barany P, Heimburger O, Stenvinkel P, Lindholm B.

Nephrology (Carlton). 2018 Jan;23(1):31-36. doi: 10.1111/nep.12927.

PMID:
27653449
39.

Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients.

Chen Z, Qureshi AR, Ripsweden J, Wennberg L, Heimburger O, Lindholm B, Barany P, Haarhaus M, Brismar TB, Stenvinkel P.

Bone. 2016 Nov;92:50-57. doi: 10.1016/j.bone.2016.08.007. Epub 2016 Aug 9.

PMID:
27519971
40.

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.

Sun J, Axelsson J, Machowska A, Heimbürger O, Bárány P, Lindholm B, Lindström K, Stenvinkel P, Qureshi AR.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1163-72. doi: 10.2215/CJN.10441015. Epub 2016 Jun 8.

41.

Peritoneal dialysis impairs nitric oxide homeostasis and may predispose infants with low systolic blood pressure to cerebral ischemia.

Carlström M, Cananau C, Checa A, Wide K, Sartz L, Svensson A, Wheelock CE, Westphal S, Békássy Z, Bárány P, Lundberg JO, Hansson S, Weitzberg E, Krmar RT.

Nitric Oxide. 2016 Aug 31;58:1-9. doi: 10.1016/j.niox.2016.05.005. Epub 2016 May 24.

PMID:
27234508
42.

Dialysis modality and nutritional status are associated with variability of inflammatory markers.

Snaedal S, Qureshi AR, Lund SH, Germanis G, Hylander B, Heimbürger O, Carrero JJ, Stenvinkel P, Bárány P.

Nephrol Dial Transplant. 2016 Aug;31(8):1320-7. doi: 10.1093/ndt/gfw104. Epub 2016 May 24.

PMID:
27220753
43.

Assessing longitudinal trends in cardiac function among pediatric patients with chronic kidney disease.

Tranæus Lindblad Y, Vavilis G, Axelsson J, Herthelius M, Bárány P.

Pediatr Nephrol. 2016 Sep;31(9):1485-97. doi: 10.1007/s00467-016-3371-z. Epub 2016 Apr 7.

PMID:
27056063
44.

Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis.

Bergman A, Qureshi AR, Haarhaus M, Lindholm B, Barany P, Heimburger O, Stenvinkel P, Anderstam B.

J Nephrol. 2017 Apr;30(2):255-262. doi: 10.1007/s40620-016-0292-7. Epub 2016 Mar 18.

PMID:
26994005
45.

The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness.

Runesson B, Gasparini A, Qureshi AR, Norin O, Evans M, Barany P, Wettermark B, Elinder CG, Carrero JJ.

Clin Kidney J. 2016 Feb;9(1):119-27. doi: 10.1093/ckj/sfv117. Epub 2015 Nov 14.

46.

Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.

Missailidis C, Hällqvist J, Qureshi AR, Barany P, Heimbürger O, Lindholm B, Stenvinkel P, Bergman P.

PLoS One. 2016 Jan 11;11(1):e0141738. doi: 10.1371/journal.pone.0141738. eCollection 2016.

47.

Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients.

Isoyama N, Machowska A, Qureshi AR, Yamamoto T, Anderstam B, Heimburger O, Barany P, Stenvinkel P, Lindholm B.

Perit Dial Int. 2016 May-Jun;36(3):269-76. doi: 10.3747/pdi.2014.00121. Epub 2015 Oct 22.

48.

Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.

Sjöberg B, Qureshi AR, Heimbürger O, Stenvinkel P, Lind L, Larsson A, Bárány P, Ärnlöv J.

J Intern Med. 2016 Feb;279(2):173-9. doi: 10.1111/joim.12411. Epub 2015 Sep 9.

49.

Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification.

Qureshi AR, Olauson H, Witasp A, Haarhaus M, Brandenburg V, Wernerson A, Lindholm B, Söderberg M, Wennberg L, Nordfors L, Ripsweden J, Barany P, Stenvinkel P.

Kidney Int. 2015 Dec;88(6):1356-1364. doi: 10.1038/ki.2015.194. Epub 2015 Sep 2.

PMID:
26331407
50.

Validation of a competitive ELISA assay for the quantification of human serum hepcidin.

Dahlfors G, Stål P, Hansson EC, Bàràny P, Sisowath C, Onelöv L, Nelson D, Eggertsen G, Marmur J, Beshara S.

Scand J Clin Lab Invest. 2015;75(8):652-8. Epub 2015 Aug 12.

PMID:
26264426

Supplemental Content

Loading ...
Support Center